natgillin/translations-raw huggingface dataset:
De hyppigste bivirkninger (≥10%) hos patienter behandlet med Tecfidera var rødme og gastrointestinale gener (dvs. diaré, kvalme, abdominalsmerter, smerter i den øverste del af abdomen).
The most common adverse reactions (incidence ≥10%) for patients treated with Tecfidera were flushing and gastrointestinal events (i.e. diarrhoea, nausea, abdominal pain, abdominal pain upper).
De hyppigste bivirkninger (≥20 %), der er set i kliniske forsøg, omfatter vasodilatation (herunder hypotension), hovedpine og hoste.
The most frequently observed adverse reactions ( 20 %) in clinical trials include vasodilatation (including hypotension), headache and cough.
De hyppigste bivirkninger (≥5 %), der medførte dosisreduktion i gruppen behandlet med lenvatinib plus everolimus, var diarré (21,0 %), trombocytopeni (6,5 %) og opkastning (6,5 %).
The most common adverse reactions (≥5%) resulting in dose reductions in the lenvatinib plus everolimus treated group were diarrhoea (21.0%), thrombocytopenia (6.5%), and vomiting (6.5%).
De hyppigste bivirkninger af Advagraf (der ses hos flere end 1 ud af 10 patienter) er rysten, hoved- pine, kvalme, diarré, nyreproblemer, for højt blodsukker, sukkersyge, for højt kaliumindhold i blodet, for højt blodtryk og søvnbesvær.
The most common side effects with Advagraf (seen in more than 1 patient in 10) are tremor (shaking), headache, nausea (feeling sick), diarrhoea, kidney problems, hyperglycaemia (raised blood glucose levels), diabetes, hyperkalaemia (raised blood potassium levels), hypertension (high blood pressure) and insomnia (difficulty sleeping).
De hyppigste bivirkninger af alle grader (ses hos patienter i RCC, GIST og pNET registreringsstudier) er appetitløshed, smagsforstyrrelser, hypertension, træthed, gastrointestinale forstyrrelser (dvs. diarré, kvalme, stomatitis, dyspepsi og opkastning), misfarvning af huden og palmoplantar erytrodysæstesi.
The most common adverse reactions of any grade (experienced by patients in RCC, GIST, and pNET registrational trials) included decreased appetite, taste disturbance, hypertension, fatigue, gastrointestinal disorders (i.e. diarrhoea, nausea, stomatitis, dyspepsia and vomiting), skin discolouration, and palmar-plantar erythrodysaesthesia syndrome.
De hyppigste bivirkninger af Daronrix (som ses hos flere end 1 ud af 10 patienter) er hovedpine, smer- te og rødme på injektionsstedet samt træthed.
The most common side effects with Daronrix (seen in more than 1 in 10 people) are headache, pain and redness at the site of the injection, and fatigue (tiredness).
De hyppigste bivirkninger af en hvilken som helst grad (hos mindst 25 % af patienterne) omfattede diarré (74 %), træthed (56 %), kvalme (50 %), appetitløshed (46 %), palmoplantar erytrodysæstesi-syndrom (PPES) (42 %), hypertension (37 %), opkastninger (32 %), vægttab (31 %) og obstipation (25 %).
The most frequent adverse reactions of any grade (experienced by at least 25% of patients) included diarrhoea (74%), fatigue (56%), nausea (50%), decreased appetite (46%), palmar-plantar erythrodysaesthesia syndrome (PPES) (42%), hypertension (37%), vomiting (32%), weight decreased (31%), and constipation (25%).
De hyppigste bivirkninger af enhver art (som kan optræde hos mere end 2 ud af 10 patienter) er nedsat antal blodplader, udslæt, tør hud og mavesmerter.
The most common side effects of any kind (which may affect more than 2 in 10 people) are decreased levels of platelets, rash, dry skin and abdominal pain.
De hyppigste bivirkninger af Grad 3-4 (hyppighed ≥1/100 til <1/10) var stomatitis, anæmi, hyperglykæmi, infektioner, træthed, diarré, pneumonitis, asteni, trombocytopeni, neutropeni, dyspnø, proteinuri, lymfopeni, hæmoragi, hypofosfatæmi, udslæt, hypertension, pneumoni, forhøjet alanin- aminotransferase (ALAT), forhøjet aspartat-aminotransferase (ASAT) og diabetes mellitus.
The most frequent Grade 3-4 adverse reactions (incidence ≥1/100 to <1/10) were stomatitis, anaemia, hyperglycaemia, infections, fatigue, diarrhoea, pneumonitis, asthenia, thrombocytopenia, neutropenia, dyspnoea, proteinuria, lymphopenia, haemorrhage, hypophosphataemia, rash, hypertension, pneumonia, alanine aminotransferase (ALT) increased, aspartate aminotransferase (AST) increased and diabetes mellitus.
De hyppigste bivirkninger af Mimpara ved sekundær hyperparathyreoidisme (som optræder hos flere end 1 ud af 10 patienter) er kvalme og opkastninger.
The most common side effects with Mimpara in secondary hyperparathyroidism (seen in more than 1 patient in 10) are nausea (feeling sick) and vomiting.
De hyppigste bivirkninger af Sebivo (som optræder hos mellem 1 og 10 patienter ud af 100) er svimmelhed, hovedpine, hoste, højere niveauer af visse enzymer i blodet (amylase, lipase, kreatin- fosfokinase og alanin-aminotransferase), diarré, kvalme, mavesmerter, hududslæt og træthed.
The most common side effects with Sebivo (seen in between 1 and 10 patients in 100) are dizziness, headache, cough, increased levels of some enzymes in the blood (amylase, lipase, creatine phosphokinase and alanine aminotransferase), diarrhoea, nausea (feeling sick), abdominal pain (stomach ache), skin rash and fatigue (tiredness).
De hyppigste bivirkninger af Tasigna (som ses hos flere end 1 ud af 10 patienter) er trombocytopeni (lavt antal blodplader), neutropeni (lavt antal hvide blodlegemer), anæmi (lavt antal røde blodlegemer), hovedpine, kvalme, udslæt, kløe, muskelsmerter og træthed.
The most common side effects with Tasigna (seen in more than 1 patient in 10) are thrombocytopenia (low blood platelet counts), neutropenia (low white blood cell counts), anaemia (low red blood cell counts), headache, nausea (feeling sick), rash, pruritus (itching), myalgia (muscle pain) and fatigue (tiredness).
De hyppigste bivirkninger af Truvada (som ses hos flere end 1 ud af 10 patienter) er hypofosfatæmi (for lavt fosfatindhold i blodet), hovedpine, svimmelhed, diarré, opkastning, kvalme, udslet, kraftesløshed og forhøjet indhold i blodet af kreatinkinase (et enzym, der findes i musklerne).
The most common side effects with Truvada (seen in more than 1 patient in 10) are hypophosphataemia (low levels of phosphates in the blood), headache, dizziness, diarrhoea, vomiting, nausea (feeling sick), rash, weakness and raised blood levels of creatine kinase (an enzyme found in muscles).
De hyppigste bivirkninger Blod og lymfesystem
Most frequent adverse reactions Blood and lymphatic system disorders
De hyppigste bivirkninger er asteni/træthed, hedestigninger, hovedpine og hypertension.
The most common adverse reactions are asthenia/fatigue, hot flush, headache, and hypertension.
De hyppigste bivirkninger er flatulens og obstipation – begge inden for systemorganklassen mave- tarm-kanalen.
The most frequently occurring adverse reactions are flatulence and constipation, found within the gastrointestinal disorders system organ class.
De hyppigste bivirkninger er flydere i glaslegemet (små, ofte uregelmæssige, mørke former i synsfeltet), øjensmerter, fotopsi (opfattelse af lysglimt i synsfeltet) og konjunktival blødning (blødning i bindehinden, der dækker den hvide del af øjet).
The most common side effects are vitreous floaters (small, often irregular, dark shapes in the field of vision), eye pain and photopsia (flashes of light in the field of vision), as well as conjunctival haemorrhage (bleeding of the membrane that lies over the white part of the eye).
De hyppigste bivirkninger er smerter i skeletmuskulaturen som knoglesmerter og myalgi.
The most frequent adverse reactions are musculoskeletal pains such as bone pain and myalgia.
De hyppigste bivirkninger er smerter i skeletmuskulaturen.
The most frequent undesirable effects are musculoskeletal pains.
De hyppigste bivirkninger er, at man bliver søvnig, føler at man skal kaste op eller bliver svimmel.
The most common side effects are feeling sleepy, sick or dizzy.
De hyppigste bivirkninger for TESLASCAN (som kunne observeres hos mellem 1 og 10 patienter ud af 100) er hovedpine, kvalme, rødme og varmefornemmelse.
The most common side effects with TESLASCAN (seen in between 1 and 10 patients in 100) are headache, nausea (feeling sick), flushing and feeling hot.
De hyppigste bivirkninger forbundet med Esmya (som optræder hos flere end 1 ud af 10 patienter) er amenoré (manglende menstruation) og fortykkelse af livmoderslimhinden.
The most common side effects associated with Esmya (seen in more than 1 in 10 patients) are amenorrhea (absence of menstrual period) and endometrial thickening (thickening of the lining of the womb).
De hyppigste bivirkninger hos både de Circadin- og de placebobehandlede grupper var hovedpine, nasopharyngitis, rygsmerte og artralgi, som var almindelige ifølge MedDRA-definitionen.
The most common adverse reactions were headache, nasopharyngitis, back pain, and arthralgia , which were common, by MedDRA definition, in both the Circadin and placebo treated groups.
De hyppigste bivirkninger hos de bosentan- og placebobehandlede patienter var henholdsvis anæmi eller hæmoglobinreduktion (7 og 2 patienter), generaliseret ødem (3 og 0 patienter) og opkastning (2 og 0 patienter).
The most frequent adverse events in the bosentan- and the placebo-treated patients were, respectively, anaemia or haemoglobin decrease (7 and 2 patients), generalised oedema (3 and 0 patients), and vomiting (2 and 0 patients).
De hyppigste bivirkninger hos hunde er lette og midlertidige forstyrrelser i fordøjelsessystemet, f.eks. opkastning eller løs afføring.
The most common side effects in dogs are slight and temporary digestive system disorders such as vomiting or loose stools.
De hyppigste bivirkninger hos patienter, der får Xofigo (meget almindelige [kan forekomme hos flere end 1 ud af 10 behandlede]) er:
The most frequent side effects in patients receiving Xofigo (very common [may affect more than 1 in 10 people]) are:
De hyppigste bivirkninger hos voksne, der får Orencia (som optræder hos flere end 1 ud af 10 patienter), er infektioner i de øvre luftveje (næse og svælg).
The most common side effects in adults taking Orencia (seen in more than 1 patient in 10) are upper respiratory tract infections (nose and throat infection).
De hyppigste bivirkninger hos yngre patienter (som optræder hos mellem 1 og 10 ud af 100 patienter), er infektioner i de øvre luftveje og ørerne, blod i urinen og feber.
In younger patients, the most common side effects (seen in between 1 and 10 in 100 patients) are upper respiratory tract infections, ear infection, blood in the urine and fever.
De hyppigste bivirkninger i forbindelse med Viraferon (indberettet hos flere end 1 ud af 10 patienter) er leukopeni (lavt antal hvide blodlegemer), appetitløshed, depression, søvnløshed, angst, ophidselse, nervøsitet, svimmelhed, hovedpine, nedsat koncentrationsevne, mundtørhed, sløret syn, kvalme eller opkastning mavesmerter, diarré, betændelse i mundslimhinden (stomatitis), dyspepsi (fordøjelsesbesvær), hårtab, øget svedafsondring, muskelsmerter, ledsmerter, smerter i muskler og knogler, betændelse på indstiksstedet, træthed, kulderystelser, feber, influenzalignende symptomer, slaphed, irritabilitet, brystsmerter, ubehag og vægttab.
The most common side effects with Viraferon in adults (seen in more than 1 patient in 10) are leucopenia (low white blood cell counts), anorexia (loss of appetite), depression, insomnia (difficulty sleeping), anxiety, agitation, nervousness, dizziness, headache, impaired concentration, dry mouth, blurred vision, nausea (feeling sick) or vomiting, abdominal (tummy) pain, diarrhoea, stomatitis (inflammation of the lining of the mouth), dyspepsia (indigestion), alopecia (hair loss), increased sweating, myalgia (muscle pain), arthralgia (joint pain), musculoskeletal pain (pain in the muscles and bones), inflammation at the site of the injection, fatigue (tiredness), rigors (shaking chills), fever, flu- like symptoms, asthenia (weakness), irritability, chest pain, malaise (feeling unwell) and weight loss.
De hyppigste bivirkninger i løbet af behandlingen med Olysioa (som optræder hos mere end 1 ud af 10 patienter) er kvalme, udslæt, kløe og dyspnø (vejrtrækningsbesvær).
The most common side effects during treatment with Olysio (which may affect more than 1 in 10 people) are nausea (feeling sick), rash, pruritus (itching), and dyspnoea (difficulty breathing).
De hyppigste bivirkninger i vareniclin-gruppen var kvalme (23,8% vs.
The most common adverse events in subjects taking varenicline were nausea (23.8% vs.
De hyppigste bivirkninger indberettet fra kliniske forsøg var feber, kvalme, opkastning, træthed, arytmi, kuldegysninger, smerte, sårinfektion og hudreaktioner.
The most frequent adverse reactions reported in clinical trials were fever, nausea, vomiting, fatigue, arrhythmia, chills, pain, wound infection and skin reaction.
De hyppigste bivirkninger indberettet under kliniske studier og som spontane indberetninger er diarré, kvalme, udslæt, hovedpine og opkastning.
The most frequent adverse reactions reported in clinical trials and as spontaneous reports are diarrhoea, nausea, rash, headache and vomiting.
De hyppigste bivirkninger med Adempas (som kan forekomme hos mere end 1 ud af hver 10 behandlede) er hovedpine, svimmelhed, halsbrand (dyspepsi), hævelse især af ankler og fødder (perifert ødem), kvalme, diarré og opkastning.
The most common side effects with Adempas (which may affect more than 1 in 10 people) are headache, dizziness, dyspepsia (heartburn), peripheral oedema (swelling, especially of the ankles and feet), nausea (feeling sick), diarrhoea and vomiting.
De hyppigste bivirkninger med Equisolon (som optræder hos mere end 1 ud af 10 heste) er undertrykkelse af produktionen af det naturlige binyrebarkhormon kortisol, der er vigtigt for kroppens reaktion på stress, og stigning i blodets indhold af fedtstoffer af typen triglycerider.
The most common side effects (seen in more than 1 in 10 horses) with Equisolon are suppression of production of cortisol (a natural corticosteroid important in the body’s response to stress), and an increase in the level of triglycerides (a type of fat) in the blood.
De hyppigste bivirkninger med Lonquex (som kan forekomme hos flere end 1 ud af 10 behandlede) er knogle- og muskelsmerter, der normalt er lette til moderate og kan behandles med almindelig smertestillende medicin.
The most common side effects with Lonquex (which may affect more than 1 in 10 patients) are bone and muscle pain, which are generally mild to moderate in severity and can be treated with standard painkillers.
De hyppigste bivirkninger med Opsumit (som kan forekomme hos flere end 1 ud af 10 personer) er inflammation af næse og hals (nasofaryngitis), inflammation af luftvejene i lungerne (bronkitis), nedsat antal røde blodlegemer (anæmi) og hovedpine.
The most common side effects with Opsumit (which may affect more than 1 in 10 people) are nasopharyngitis (inflammation of the nose and throat), bronchitis (inflammation of the airways in the lungs), anaemia (low red blood cell counts) and headache.
De hyppigste bivirkninger med Relvar Ellipta (som kan forekomme hos flere end 1 ud af 10 behandlede) er hovedpine og betændelse i næse og svælg (nasofaryngitis).
The most common side effects with Relvar Ellipta (which may affect more than 1 in 10 people) are headache and nasopharyngitis (inflammation of the nose and throat).
De hyppigste bivirkninger med Stribild er kvalme og diarré, som forekom hos mere end 1 ud af hver 10 behandlede.
The most common side effects with Stribild are nausea (feeling sick) and diarrhoea, which were seen to affect more than 1 in 10 people.
De hyppigste bivirkninger med Xigduo (som optræder hos mere end 1 ud af 10 patienter), er for lavt blodsukker (hypoglykæmi) (ved anvendelse sammen med insulin eller et sulfonylurinstof) og symptomer i mave-tarmkanalen.
The most common side effects with Xigduo (which may affect more than 1 in 10 people) are hypoglycaemia (when used together with insulin or a sulphonylurea) and gastrointestinal symptoms (symptoms affecting the stomach and gut).
De hyppigste bivirkninger med ZACTRAN (som kan forekomme hos op til 1 ud af 10 stykker kvæg) er hævelse på injektionsstedet.
The most common side effects with ZACTRAN in cattle (which may affect more than 1 in 10 cattle) are swellings at the site of injection.
De hyppigste bivirkninger rapporteret hos ≥20% af patienterne var diarré (78,5%), kvalme (42,1%), trombocytopeni (38,5%), opkastning (37,1%), abdominalsmerte (33,4%), udslæt (32,4%), anæmi (27,4%), pyreksi (23,4%) og forhøjet alaninaminotransferase (22,3%).
The most frequent adverse reactions reported for  20% of patients were diarrhoea (78.5%), nausea (42.1%), thrombocytopenia (38.5%), vomiting (37.1%), abdominal pain (33.4%), rash (32.4%), anaemia (27.4%), pyrexia (23.4%), and alanine aminotranserase increased (22.3%).
De hyppigste bivirkninger var infektioner, hovedsageligt i de øvre luftveje.
The most frequent adverse drug reactions were infections predominantly of the upper respiratory tract.
De hyppigste bivirkninger var træthed, gastro-intestinale forstyrrelser, hæmatologiske forstyrrelser, respiratoriske forstyrrelser, forstyrrelser i nervesystemet og pyreksi.
The most frequently occurring adverse events were fatigue; gastrointestinal disorders; haematological disorders; respiratory disorders; nervous system disorders; and pyrexia.
De hyppigste bivirkninger var øjensmerter og øjenkløe, som forekom hos 1 % til 2,0 % af patienterne.
The most common adverse drug reactions were eye pain and eye pruritus, occurring in 1% to of 2.0% of patients.
De hyppigste bivirkninger var øjensmerter og øjenkløe, som forekom hos 1-2,0 % af patienterne.
The most common adverse drug reactions were eye pain and eye pruritus occurring in 1% to 2.0% of patients.
De hyppigste bivirkninger ved Ablavar (som optræder hos flere end 1 ud af 100 patienter) er hovedpine, paræstesi (prikkende og stikkende fornemmelse), dysgeusi (smagsforstyrrelser), en brændende fornemmelse, vasodilatation (udvidelse af blodkarrene, herunder rødmen), kvalme, pruritus (kløe) og kuldefornemmelse.
The most common side effects with Ablavar (seen in more than 1 patient in 100) are headache, paraesthesia (unusual sensations like pins and needles), dysgeusia (taste disturbances), a burning sensation, vasodilatation (widening of the blood vessels, including reddening of the skin), nausea (feeling sick), pruritus (itching) and feeling cold.
De hyppigste bivirkninger ved Abseamed (som optræder hos flere end 1 ud af 10 patienter) er kvalme, diarré, opkastning, feber og hovedpine.
The most common side effects with Abseamed (seen in more than 1 patient in 10) are nausea (feeling sick), diarrhoea, vomiting, pyrexia (fever) and headache.
De hyppigste bivirkninger ved Activyl Tick Plus er forbigående kløe, erytem (rødme af huden) og hårtab på påføringsstedet.
The main side effects seen with Activyl Tick Plus are transitory scratching, erythema (reddening of the skin) and hair loss at the application site.
De hyppigste bivirkninger ved Advate (som optræder hos 1 til 10 patienter ud af 100) er udvikling af antistoffer mod faktor VIII, svimmelhed, hovedpine og pyreksi (feber).
The most common side effects with Advate (seen in between 1 to 10 patients in 100) include the development of antibodies against factor VIII, dizziness, headache and pyrexia (fever).
De hyppigste bivirkninger ved Afinitor (som optræder hos mere end 1 ud af 10 patienter) er udslæt, kløe (pruritus), kvalme, nedsat appetit, smagsforstyrrelser (dysgeusi), hovedpine, vægttab, hævelse af især ankler og fødder (perifere ødemer), hoste, lavt antal røde blodlegemer (anæmi), træthed, diarré, slaphed (asteni), infektioner, betændelse i mundslimhinden (stomatitis), forhøjet blodsukker (hyperglykæmi), forhøjet blodkolesterol (hyperkolesterolæmi), betændelse i lungerne (pneumoni) og næseblod (epistaxis).
The most common side effects with Afinitor (which may affect more than 1 in 10 people) are rash, pruritus (itching), nausea, decreased appetite, dysgeusia (taste disturbances), headache, decreased weight, peripheral oedema (swelling, especially of the ankles and feet), cough, anaemia (low red blood cell counts), fatigue (tiredness), diarrhoea, asthenia (weakness), infections, stomatitis (inflammation of the lining of the mouth), hyperglycaemia (high blood glucose levels), hypercholesterolaemia (high blood cholesterol levels), pneumonitis (inflammation of the lungs) and epistaxis (nosebleeds).
De hyppigste bivirkninger ved Aflunov (som optræder hos flere end 1 ud af 10 patienter) er hovedpine, myalgi (muskelsmerter), reaktioner på injektionsstedet (hævelse, smerte, hårdhed og rødme) og træthed.
The most common side effects with Aflunov (seen in more than 1 patient in 10) are headache, myalgia (muscle pain), reactions at the site of injection (swelling, pain, induration and redness) and fatigue (tiredness).
De hyppigste bivirkninger ved Anoro (som optræder hos 1-10 ud af hver 100 patienter) er forkølelse (øvre luftvejsinfektioner), urinvejsinfektioner, halsbetændelse (faryngitis), bihulebetændelse (sinuitis), næse/svælgbetændelse (nasofaryngitis), hovedpine, hoste, smerter i mund og hals, forstoppelse og mundtørhed.
The most common side effect with Anoro (seen in between 1 and 10 patients in 100) are upper respiratory tract infections (colds), urinary tract infections (infection of the structures that carry urine), pharyngitis (inflammation of the throat), sinusitis (inflammation of the sinuses), nasopharyngitis (inflammation of the nose and throat), headache, cough, ororpharyngeal pain (pain in the mouth and throat), constipation and dry mouth.
De hyppigste bivirkninger ved Arzerra (som optræder hos flere end én ud af 10 patienter) er infektioner i de nedre luftveje (infektioner i lungerne såsom pneumoni), infektioner i de øvre luftveje (forkølelse), neutropeni (lavt niveau af neutrofiler, en type hvide blodlegemer), anæmi (lavt niveau af røde blodlegemer), kvalme, feber og udslæt.
The most common side effects with Arzerra (seen in more than 1 patient in 10) are lower respiratory tract infection (infection of the lungs such as pneumonia), upper respiratory tract infection (colds), neutropenia (low levels of neutrophils, a type of white blood cell), anaemia (low red blood cell counts), nausea (feeling sick), pyrexia (fever) and rash.
De hyppigste bivirkninger ved Avandia (som ses hos mellem 1 og 10 patienter ud af 100) er anæmi (lavt antal røde blodlegemer) og ødemer (hævelser) samt hypercholesterolæmi (højt blodkolesterol), hypertriglyceridæmi (forhøjet indhold af triglycerider i blodet, en bestemt type fedtstoffer), hyperlipæmi (øget fedtindhold i blodet), vægtøgning, øget appetit, hjerteiskæmi (nedsat ilttilførsel til hjertemusklen), forstoppelse, knoglefrakturer (knoglebrud) og hypoglykæmi (lavt blodsukkerniveau).
The most common side effects with Avandia (seen in between 1 and 10 patients in 100) are anaemia (low red blood cell counts) and oedema (swelling), as well as hypercholesterolaemia (high blood cholesterol levels), hypertriglyceridaemia (high blood levels of triglycerides, a type of fat), hyperlipaemia (high blood fat levels), weight increase, increased appetite, cardiac ischaemia (reduced oxygen supply to the heart muscle), constipation, bone fractures (broken bones) and hypoglycaemia (low blood glucose levels).
De hyppigste bivirkninger ved Avastin er hypertension (forhøjet blodtryk), træthed eller asteni (kraftesløshed), diarré og mavesmerter.
The most common side effects with Avastin are hypertension (high blood pressure), fatigue or asthenia (weakness), diarrhoea and abdominal pain.
De hyppigste bivirkninger ved Avonex (som optræder hos flere end 1 ud af 10 patienter) er hovedpine, influenzalignende symptomer, feber, kulderystelser og svedtendens.
The most common side effects with Avonex (seen in more than 1 patient in 10) are headache, flu-like symptoms, pyrexia (fever), chills and sweating.
De hyppigste bivirkninger ved Benlysta (som optræder hos flere end 1 ud af 10 patienter) er bakterieinfektioner, f.eks. bronkitis (betændelse i luftvejene i lungerne) og cystitis (blærebetændelse), og diarré og kvalme.
The most common side effects with Benlysta (seen in more than 1 patient in 10) are bacterial infections, such as bronchitis (inflammation of the airways in the lungs) and cystitis (inflammation in the bladder), diarrhoea and nausea (feeling sick).